Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
PerkinElmer launches top technologies at the Society for Laboratory Automation and Screening (SLAS) in San Diego. Highlighted products include JANUS® G3 Blood iQ™ Workstation, Sciclone® G3 NGSx HT Workstation as well as Opera Phenix® Plus High Content Screening System.
To ensure the safety of medicines, PerkinElmer offers pharma companies a comprehensive solution to detect N-nitrosodimethylamine (NDMA) impurity in ranitidine.
TPerkinElmer’s liquid handling workstations facilitate sample tracking by incorporating automated barcode scanning into every step of sample processing.
Lead scientist of the eXXpedition research boat Dr. Winnie Courtene-Jones shares how the portable and powerful Spectrum Two FT/IR Spectrometer is being used on board to test for microplastics in our oceans.
As an AI-driven technology solution provider, PerkinElmer is enhancing researchers’ ability to analyze massive amounts of data in a timely fashion.
Together with PerkinElmer, New York State has screened the first infant for Duchenne as part Parent Project Muscular Dystrophy’s (PPMD's) Newborn Screening Pilot.
Cannabis and hemp labs need high quality, end-to-end testing and analysis solutions to keep up with growing demand and regulations. PerkinElmer is teaming up with Emerald Scientific to help.
With PerkinElmer’s spectrometer on board, the all-women research voyage is on the mission of identifying and documenting microplastics during the sails.
Duchenne Muscular Dystrophy is a rare genetic disorder and the most prevalent type of muscular dystrophy. The FDA has approved PerkinElmer’s GSP® Neonatal Creatine Kinase –MM (CK-MM) kit for DMD screening.
ESPGHAN recently updated guidelines for the diagnosis of Celiac disease, which are expected to be more widespread and easy for both patients and gastroenterologists.
Have you ever thought AI can help diagnose genetic disorders? A Boston company is helping clinicians narrow down a patient’s diagnosis out of thousands of disorders with facial recognition technology.
AI and machine learning can help pharmas repurpose failed clinical trial data to drive new breakthroughs and treatments. David Wang, Masha Hoffey and Dr. Simone Sharma discuss key considerations and best practices.
Perkin Elmer's new MuviCyte live-cell imaging system helps researcher study cell behavior and function in new ways. Karin Boettcher weighs in on the importance of controlling environmental parameters with advanced innovation.
PerkinElmer offers high-throughput platforms for electrophoresis-based biomolecule separation, sizing, and quantitation.
Mycotoxin testing for grains is a key step in securing global food safety. PerkinElmer’s Mark McBeath discusses best practices and innovative solutions for analysis from strips to LC-MS/MS.
PerkinElmer Genomics will begin processing about 2,500 samples with the Vanadis non-invasive prenatal testing (NIPT) system in Pittsburgh and Kuala Lumpur.
In this article PerkinElmer’s Toby Astill and Aaron Hineman weigh in on the use of ICP-MS to tackle heavy metals testing in cannabis.
Rice is a mega-staple for global consumers and testing for rice quality is key. The newPaddyCheck testing platform speeds sample throughput, increases accuracy and allows for grain testing at the paddy stage whether in-field or in a lab.
PerkinElmer launched the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit, which tests spent embryo culture media for chromosomal abnormalities during in vitro treatment.
PerkinElmer is exploring the use of deep learning methods to improve analysis of image data from high content screening—in some cases, solving problems that conventional algorithms can’t.
Food safety is paramount. In this byline, PerkinElmer’s Greg Sears discusses advances in testing and analysis for everything from heavy metals, pesticides and mycotoxins, to foodborne pathogens and antibiotics.
A new clinical study further validates PerkinElmer’s Vanadis non-invasive prenatal testing (NIPT) system, which uses fully-automated imaging instead of DNA sequencing or PCR amplification.
Dr. Madhuri Hegde of PerkinElmer Genomics talks about the critical role that genetic counseling plays in consumer-initiated DNA testing today.
In this video, Justin Waldron of EUROIMMUN provides an overview of the high-capacity EUROLabWorkstation at AACC 2019.
To battle food fraud, PerkinElmer’s Greg Sears and Stefan Tordenmalm explain how robust analytical and informatics solutions can detect and analyze adulterants throughout the supply chain.
Beachcombing in Spain drew PerkinElmer’s Ian Robertson into not only his main field of research but an endeavor that fuels debate on microplastics in bottled water.
Linh Hoang, PerkinElmer’s vice president of Reproductive Health, spoke with Bloomberg about molecular testing options available right now for screening newborns with SMA (spinal muscular atrophy).
Angelo Filosa of PerkinElmer OneSource explains how working with a relocation service provider can minimize disruptions to daily operations and ensure a successful lab move.
In this article, Dr. Marc Pollmann, EUROIMMUN biologist, outlines the factors that play into accurate identification, diagnosis and treatment of tickborne illnesses like Lyme disease.
PerkinElmer and FDNA have partnered to offer genomic services paired with next-generation phenotyping technologies. The new service combines PerkinElmer Genomics' Ordered Data Interpretation Network (ODIN) software platform with FDNA's Face2Gene facial analysis technology.
Today more than half of all US citizens -- and people from 44 other countries -- have access to legal medical cannabis. As this market continues to grow and becomes more mainstream, calls for regulation and the need for the cannabis industry to ensure patient and consumer safety will similarly increase.
Prahlad Singh, president and chief operating officer, shares an update on PerkinElmer's new office facility in Singapore and growing customer base throughout Southeast Asia.
PerkinElmer is supporting the launch of Parent Project Muscular Dystrophy's (PPMD) pilot program to screen newborns in New York state for Duchenne—one of the most common forms of muscular dystrophy.
Researchers are looking for ways to more easily and effectively access, analyze and spotlight scientific data that is growing in volume and complexity and often dispersed across hard-to-access silos.
PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.
PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.
As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.
PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.